Comparing treatment strategies with Alzheimer's medications
Part of Brain & nervous system, Mental health clinical trials.
This study compares two different ways of prescribing cholinesterase inhibitors (common Alzheimer's medications) to see which works better over time. If you or your loved one has mild to moderate Alzheimer's and has never taken these medications, this trial may help find the best treatment approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your loved one must have a diagnosis of Alzheimer's disease (mild to moderate stage).
- Must not have taken any cholinesterase inhibitor medications before (like donepezil, rivastigmine, or galantamine).
- Must be 50 years or older.
- Must live at home (not in a nursing home or long-term care facility) and have a caregiver to help.
- Must be able to consent to participate (or have a legal representative if needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether changing caffeine intake can improve thinking and brain function in people with Alzheimer’s disease. You may qualify if you can follow a low-caffeine diet and have stable Alzheimer’s treatment and sleep/heart conditions.
This trial tests a drug called masitinib to see if it can help people with mild Alzheimer's disease. You'd get either the drug or a placebo, and doctors will check if your daily living skills and memory slow their decline.
This study looks at how effective a treatment is in people newly diagnosed with mild to moderate Alzheimer’s disease. It also involves health and medication history checks and likely stool (fecal) sample collection to monitor effects.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This trial tests whether a special form of a dietary fat called tricaprilin can help people with mild-to-moderate Alzheimer's disease. It may provide an alternative or add-on to current treatments to help with memory and thinking.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.